Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) Trial

Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) Trial
99 years or below
All
Phase 3
1 Location

Brief description of study

The study is a multinational, open-label, multicenter randomized controlled trial. The primary objective is to evaluate whether cardiac output monitoring guided administration of IV fluids and low dose inotrope infusion in patients undergoing major elective gastrointestinal surgery results in reduced incidence of post-operative infection and reduced mortality and morbidity.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: TBD, tbd, tbd
  • Age: 99 years or below
  • Gender: All
Updated on 27 Aug 2018. Study ID: 829214

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.